A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/1999
11/04/1999	CA2327317A1 Polynucleotides isolated from skin cells and methods for their use
11/04/1999	CA2270670A1 Skin barrier composition
11/03/1999	EP0953353A1 Use of procyanidolic oligomers or anthocyanosides as anti-urease agents
11/03/1999	EP0953344A1 Use of at least one hydroxystilbene in a composition to stimulate desquamation of the skin and compositions containing it
11/03/1999	EP0953338A1 Packaging device for a product
11/03/1999	EP0953335A1 Solid deodorant composition
11/03/1999	EP0952975A1 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same
11/03/1999	EP0952974A1 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
11/03/1999	EP0952839A2 Green ointment
11/03/1999	EP0952836A1 New use
11/03/1999	EP0859595B1 Therapeutic preparation for the transdermal administration of active substances
11/03/1999	EP0754058B1 Wound healing
11/03/1999	CN1234071A Keratinocyte grouth factor -2(KGF-2 or fibroblast growth factor-12, FGF-12)
11/03/1999	CN1234031A Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the prodn. of tumor necrosis factor (TNF)
11/03/1999	CN1233948A Aqueous antimicrobial liquid cleaning formulations
11/03/1999	CN1233482A Application of selenium-rich glossy ganoderma in medicine for treating psoriasis
11/03/1999	CN1233471A Medicinal prepns. for treating underarm odour and beriberi
11/02/1999	US5977359 Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present
11/02/1999	US5977311 53BP2 complexes
11/02/1999	US5977108 Leukemia
11/02/1999	US5977103 Substituted imidazole compounds
11/02/1999	US5977102 Inhibitory effect on signal transduction mediated by tyrosine kinases or epidermal growth factor; antitumor,-carcinogenic, -metastasis,-proliferation agents and -inflammatory agents; psoriasis; angiogenesis inhibitors; immunology;
11/02/1999	US5977095 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and respiratory distress syndrome
11/02/1999	US5976837 Secreted proteins and polynucleotides encoding them
11/02/1999	US5976558 Silicone-containing derivatives of salicylic acid which have desquamating properties
11/02/1999	US5976556 Combination of acid protease enzymes and acidic buffers and uses thereof
11/02/1999	US5976513 UV protection compositions
10/1999
10/28/1999	WO1999054469A1 B-cell growth factor related protein
10/28/1999	WO1999054359A1 Matrix binding factor
10/28/1999	WO1999054333A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
10/28/1999	WO1999054284A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
10/28/1999	WO1999053968A1 Solid borate-diol interaction products for use in wounds
10/28/1999	WO1999053961A1 Peptides for efficient gene transfer
10/28/1999	WO1999053949A2 Combination of antigen pulsed apcs and interleukin 12 for tumor and viral therapy
10/28/1999	WO1999053943A2 Therapeutic angiogenic factors and methods for their use
10/28/1999	WO1999053935A1 Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga
10/28/1999	WO1999053923A1 Pharmaceutical composition
10/28/1999	WO1999053897A2 Topical formulation comprising poloxamers and further microbicides, and an applicator
10/28/1999	WO1999035243A9 Extension of cellular lifespan, methods and reagents
10/28/1999	CA2329010A1 Therapeutic angiogenic factors and methods for their use
10/28/1999	CA2328463A1 Matrix binding factor
10/28/1999	CA2328413A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
10/28/1999	CA2326406A1 Combination of antigen pulsed apcs and interleukin 12 for tumor and viral therapy
10/28/1999	CA2325848A1 B-cell growth factor related protein
10/27/1999	EP0952224A2 Method for producing transgenic cucumber that produces high levels of superoxide dismutase
10/27/1999	EP0951537A1 Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses
10/27/1999	EP0951472A1 Peptide compositions with growth factor-like activity
10/27/1999	EP0951471A1 Cycloalkyl inhibitors of protein farnesyltransferase
10/27/1999	EP0951294A1 Wound healing formulations containing human plasma fibronectin
10/27/1999	CN1233256A Dipeptide benzamidine as a kininogenase inhibitor
10/27/1999	CN1233254A Purine L-nucleosides, analogs and uses thereof
10/27/1999	CN1233183A Pharmaceutical and cosmetic antiacne formulations containing plant extracts (Krameria triandra or mesua ferrea)
10/27/1999	CN1233176A Substituted tricyclics
10/27/1999	CN1233173A Therapeutic methods and compositions involving isoflavones
10/27/1999	CN1233168A Wrinkling modifiers
10/27/1999	CN1232665A Antimicrobial composition
10/26/1999	US5973007 Use of inhibitors of retinoic acid activity for wound healing
10/26/1999	US5972982 Containing 5-to 9-membered heteroaryl mono- or bicyclic ring system having no more than 1 carbonyl carbon in the ring system; viricides, bactericides
10/26/1999	US5972962 Treatment of pruritus
10/26/1999	US5972928 Administering an antigrowth agent
10/26/1999	US5972917 Treatment and prophylaxis of hyperparathyroidism and hyperproliferative diseases, and in the modulation of the immune and inflammatory responses as well as the treatment of bone depletive disorders
10/26/1999	US5972908 Collagen-based composition and process for preparing it
10/26/1999	US5972905 Use of oligosaccharides for the treatment of pruritus cutaneus associated with renal failure
10/26/1999	US5972896 Antiangiogenic peptides and methods for inhibiting angiogenesis
10/26/1999	US5972892 For reducing or eliminating the skin irritant side-effect of a therapeutic composition; a stabilizer for desensitization
10/26/1999	US5972701 Nucleotide sequence of ribo- or deoxyribonucleotides which may have modified sugars, bases, or phosphates; for hybridization and cleavage of rna targets; treatment of disease
10/26/1999	US5972606 A polypeptide; treating osteoporosis, eating disorders, brain disorders, adult respiratory disease syndrome, huntington'sdisease, ulcers, cardiovascular disorders, parkinson's disease;
10/26/1999	US5972365 Remedy for prurigo
10/26/1999	US5972358 A hydroalcohol detackifying mixture consist of stearoxy trimethylsilane, cetyl lactate, cyclomethicone, c12-c15 alkyl lactate and alcohol selected from ethanol, propanol, isopropanol and water; topical skin care products
10/26/1999	US5972355 Stable water-containing cosmetic or pharmaceutical compositions which comprise biologically active agent and enzyme-based oxygen-scavenging antioxidant system
10/26/1999	US5972345 Comprising saw palmetto extract, african pygeum extract, stinging nettle extract
10/26/1999	US5972344 Administering extract to treat pain, inflammation, itching, smooth muscle tissue, prevent sunburn
10/26/1999	US5972343 Topical hair growing solution having selected portions of rice and wheat bran, zymotic vegetable flour enzyme, water and and a citrus extract such as p-50 (grapefruit seed extract)
10/26/1999	US5972341 Products extracted from a plant of the genus Commiphora, particularly the Commiphora mukul plant, extracts containing same and applications thereof, for example in cosmetics
10/26/1999	US5972340 Slimming cream based on plants
10/26/1999	US5972338 ?tie? or ?tie? are acronyms, which stand for ?tyrosine kinase containing ig and egf homology domains?; present invention concerns novel human tie ligand homologues with powerful effects on vasculature; antitumor agents
10/26/1999	US5972335 Compositions for promoting the healing of wounds or fibrotic disorders comprising at least one agent specific to either a growth factor or a protein associated therewith; antibodies
10/26/1999	US5972317 Nail-permeable medication means is disclosed for delivering a medicament through nails, claws, hoofs, or other similar hardened tissue of dermal derivation; includes proteolytic enzyme and drug selected to treat specific disease
10/21/1999	WO1999052910A1 Bicyclic hydroxamic acid derivatives
10/21/1999	WO1999052898A1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors
10/21/1999	WO1999052890A1 Chromanone and thiochromanone derivatives
10/21/1999	WO1999052889A1 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides
10/21/1999	WO1999052862A1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors
10/21/1999	WO1999052555A1 Methods and compositions using norastemizole in combination with leukotriene inhibitors
10/21/1999	WO1999052554A1 Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
10/21/1999	WO1999052536A1 Use of at least a plant extract of the compositae family, such as the genus bellis
10/21/1999	WO1999052534A1 Use of steroidal alkaloid derivatives as inhibitors of hedgehog signaling pathways
10/21/1999	WO1999052524A1 Use of cannabinoids as anti-inflammatory agents
10/21/1999	WO1999052514A2 Pharmaceutical composition and combination preparation for immunosuppressive therapy
10/21/1999	WO1999052495A1 External preparations for treating dry skin
10/21/1999	WO1999052493A2 Compounds that inhibit the binding of integrins to their receptors
10/21/1999	WO1999015654A3 Tie receptor tyrosine kinase ligand homologues
10/21/1999	CA2328075A1 Methods and compositions using norastemizole in combination with leukotriene inhibitors
10/21/1999	CA2327431A1 Pharmaceutical composition
10/20/1999	EP0950104A1 NOVEL FELINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, PROTEINS AND USES THEREOF
10/20/1999	EP0950100A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12)
10/20/1999	EP0950065A1 Peptide as diagnostic and therapeutic agent for autoimmune diseases
10/20/1999	EP0949919A1 A process for stabilizing levogyre ascorbic acid (laa) and stable laa compositions
10/20/1999	EP0949902A2 Cosmetic preparation with a peptide addition
10/20/1999	EP0949901A1 Cosmetic cleansing and skin care preparation containing plant and algae extracts

1 ... 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 ... 1065